paxlovid
pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.
tavneos
vifor fresenius medical care renal pharma france - avacopan - microscopic polyangiitis; wegener granulomatosis - immunosoppressori - tavneos, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (gpa) or microscopic polyangiitis (mpa).
tavneos 10 mg capsule rigide
vifor fresenius medical care renal pharma ltd. - avacopanum - capsule rigide - avacopanum 10 mg, macrogolglyceroli hydroxystearas 245 mg, macrogolum 4000, kapselhülle: e 172 (rubrum), e 172 (flavum), e 171, gelatina, polysorbatum 80, drucktinte: e 172 (nigrum), pro capsula. - behandlung erwachsener patienten mit schwerer aktiver vaskulitis (granulomatose mit polyangiitis (gpa) oder mikroskopischer polyangiitis (mpa)) - synthetika
orserdu
stemline therapeutics b.v. - elacestrant - neoplasie al seno - terapia endocrina - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.
zetacain con adrenalina
intermedical srl - mepivacaina, associazioni - mepivacaina, associazioni
truqap 160 mg compresse rivestite con film
astrazeneca ag - capivasertibum - compresse rivestite con film - capivasertibum 160 mg, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum corresp. natrium max. 1.82 mg, magnesii stearas, Überzug: hypromellosum, copovidonum k 28, macrogolum 3350, polydextrosum, triglycerida media, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro compresso obducto. - carcinoma della mammella - synthetika
truqap 200 mg compresse rivestite con film
astrazeneca ag - capivasertibum - compresse rivestite con film - capivasertibum 200 mg, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum corresp. natrium max. 2.28 mg, magnesii stearas, Überzug: hypromellosum, copovidonum k 28, macrogolum 3350, polydextrosum, triglycerida media, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro compresso obducto. - carcinoma della mammella - synthetika
triasporin
italfarmaco s.p.a. - itraconazolo - itraconazolo
hepcludex
gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - antivirali per uso sistemico - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.
empressin
orpha-devel handels und vertriebs gmbh - vasopressina - vasopressina